Malaria and Malignancies- A review
Abstract
Introduction: Malaria, a parasitic disease caused by Plasmodium sp. is a substantial threat to global health. In recent years, the association of malignancies and malaria has been an interesting field of research. To date, Burkitt's lymphoma has shown a close association with Malaria in the sub-Saharan nations. The latest research targets the current anti-malarial medicines as a promising approach towards novel anti-cancer therapies. The complicated relationship between malaria, genetics, immune response, and cancer might help in exploring various pharmacological approaches that might help in the therapeutic approach to malaria and cancer. Further, in-depth in-vivo and in-vitro studies are needed to establish the link between malaria infection and cancer progression.
Aims and Objectives: This review aims to explore the key associations of malaria and various malignancies and the possible anti-cancer effects of anti-malarial drugs.
Materials and Methods: A critical review of 53 articles from 1987 to 2023 was conducted.
Conclusion:
• Endemic Burkitt's lymphoma shows a synergy with malaria, but more studies are needed to explore, for correlating the possible associations of malaria with other malignancies.
• Non-hematological malignancies were shown not to have a strong correlation with malaria.
• Anti-malarial drugs displaying anti-cancer properties could be a promising adjunct to current routine cancer treatment
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The Author(s)
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Accepted 2024-03-14
Published 2024-04-26